1. Home
  2. ETS vs PHIO Comparison

ETS vs PHIO Comparison

Compare ETS & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ETS

Elite Express Holding Inc.

N/A

Current Price

$1.48

Market Cap

12.0M

Sector

Industrials

ML Signal

N/A

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

N/A

Current Price

$0.99

Market Cap

12.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ETS
PHIO
Founded
2020
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
12.9M
IPO Year
2025
2011

Fundamental Metrics

Financial Performance
Metric
ETS
PHIO
Price
$1.48
$0.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 304.2K
99.6K
Earning Date
10-20-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $2,665,948.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 21.57
N/A
52 Week Low
$0.39
$0.81
52 Week High
$2.75
$4.19

Technical Indicators

Market Signals
Indicator
ETS
PHIO
Relative Strength Index (RSI) 48.97 40.89
Support Level $1.42 $0.98
Resistance Level $1.88 $1.12
Average True Range (ATR) 0.25 0.05
MACD -0.06 -0.00
Stochastic Oscillator 6.77 10.37

Price Performance

Historical Comparison
ETS
PHIO

About ETS Elite Express Holding Inc.

Elite Express Holding Inc is a holding company that operates through its wholly owned subsidiary and specializes in last-mile delivery services within California. Its core business focuses on retrieving packages from distribution hubs and ensuring their prompt and secure delivery to recipients doorsteps. Committed to innovation and efficiency, its mission is to optimize last-mile logistics by providing efficient, reliable delivery solutions. The company mainly competes in the route delivery industry, which has several material barriers of entry, including: Substantial time and capital investment, Technological proficiency, Regulatory barriers, Balancing service quality and cost efficiency, and Effective Management.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

Share on Social Networks: